TUCSON - Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m. Eastern Time to review 2023 third quarter results.

Participant Connection Information

Participant Dial In (Toll Free): 1-877-883-0383

Participant International Dial In: 1-412-902-6506

Participant Elite Entry Number: 9121489

Participants will need this Elite Entry number in order to join the conference. Speakers should use the Live Presenter dial in number and will not be required to provide the Elite Entry number. Participants should be asked to dial in 10-15 minutes early to join the conference, so that their information can be collected prior to the start of the conference.

Conference Replay

US Toll Free: 1-877-344-7529

International Toll: 1-412-317-0088

Canada Toll Free: 855-669-9658

Replay Access Code: 6290760

End Date: November 30, 2023

Participants will be required to state their name and company upon entering the call.

Webcast Information

URLs for Distribution

Webcast URL: https://event.choruscall.com/mediaframe/webcast.htmlwebcastid=kIfbhbnn

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

'Accelerate Diagnostics' and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc. Any trade, product or service name referenced in this document using the name 'Accelerate' is a trademark and/or property of Accelerate Diagnostics, Inc. All other company and product names may be trademarks, registered trademarks, or service marks of the companies with which they are associated.

Contact:

Laura Pierson

Tel: +1 520 365-3100

Email: investors@axdx.com

(C) 2023 Electronic News Publishing, source ENP Newswire